HomeStreet, Inc. (NASDAQ:HMST) shares moved up 0.93% in last trading session and ended the day at $19.61. HMST has a return on assets of 0.90%. HomeStreet, Inc. (NASDAQ:HMST) quarterly performance is -10.46%.
HomeStreet, Inc. (NASDAQ:HMST) announced the completion of its previously announced charter conversion from a Washington state-chartered savings bank to a Washington state-chartered commercial bank. This change is effective February 28, 2016. As a result of the bank-charter conversion, HomeStreet, Inc. will become a bank holding company subject to regulatory oversight by the Federal Reserve Board.
BlackBerry Ltd (NASDAQ:BBRY) ended the last trading day at $8.24. Company weekly volatility is calculated as 3.36% and price to cash ratio as 1.88. BlackBerry Ltd (NASDAQ:BBRY) showed a weekly performance of 5.64%.
On 6 March, BlackBerry Ltd (NASDAQ:BBRY) is exploring alternatives to make working on BBM, its messaging platform, “more convenient and fun” to support users after rival WhatsApp announced to stop its support to Canadian firm’s operating system from later this year.
On 09 March, Medifast Inc. (NYSE:MED) shares moved up 0.33% and was closed at $30.75. MED EPS growth in last 5 year was 16.50%. Medifast Inc. (NYSE:MED) year to date (YTD) performance is 1.22%.
Medifast Inc. (NYSE:MED) announced that its Board of Directors has declared a $0.25 cash dividend to its stockholders. The quarterly cash dividend of $0.25 per share is payable on May 10, 2016 to stockholders of record as of the close of business on March 21, 2016.
Sequenom Inc. (NASDAQ:SQNM) shares moved up 3.25% in last trading session and ended the day at $1.59. SQNM Gross Margin is 47.80% and its has a return on assets of -1.50%. Sequenom Inc. (NASDAQ:SQNM) quarterly performance is 37.07%.
Sequenom Inc. (NASDAQ:SQNM) announced the completion of an agreement with Anthem BlueCross. The agreement provides in-network coverage for Anthem’s California customers for Sequenom Laboratories’ noninvasive prenatal tests in both high and average risk pregnancies, beginning March 1, 2016.
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) caters to the Healthcare space. Its weekly performance is -4.01%. On the last day of trading company shares ended up at $2.63. HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) distance from 50-day simple moving average (SMA50) is 9.74%.
Canaccord Genuity reaffirmed their buy rating on shares of HTG Molecular Diagnostics Inc (NASDAQ:HTGM) in a research report published on Tuesday morning, Market Beat.com reports. They currently have a $10.00 price target on the stock.
Leave a Reply